Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
about
Neuroinflammation in Parkinson's disease and its potential as therapeutic targetInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsAgeing, neurodegeneration and brain rejuvenationPACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in miceRotenone directly induces BV2 cell activation via the p38 MAPK pathway.Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species.Pathways towards an effective immunotherapy for Parkinson's diseasePeripheral inflammation in neurodegeneration.Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified.8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats.Lessons learned from protein aggregation: toward technological and biomedical applications.Sodium salicylate protects against rotenone-induced parkinsonism in rats.Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: A dose-response meta-analysis
P2860
Q26783305-56D6D121-FE26-4EA4-84A5-8C0B11D7F292Q26795984-D19B5477-01D8-415B-82D5-73DAF9CDDE72Q26801035-9C40144F-05D6-4977-957C-5834A90CF6A0Q28071590-E797B809-3856-4AC8-B34F-67D4F58A9C90Q28397422-AEE3D75A-8F4E-4573-8E7E-EFFC7FAE0DBEQ34972939-004D91B6-8CC8-4BCF-8295-E5B8483999A3Q36164724-4792DEEB-CF6D-4838-AB86-43E3758DEB90Q37622863-C109F655-1CBA-4554-95C7-F2D6AF0BDA48Q37957125-554C3539-9F24-46FF-9A0E-47FB448BBF8CQ38094970-8E4C71AB-70BB-4F1A-9939-06D0A230E343Q41585770-9590B22E-586E-43ED-BE74-3B5F96C65FFBQ41975992-ED231F22-E29C-4FF9-947C-58384E118CF5Q46173279-F4853443-3848-4D30-8E56-674C50CE8157Q48145970-8163900A-44D9-4C93-AC3F-74E29097CA31Q58739806-8DB67B66-916D-4F3E-9F9C-22AD7FFFE627
P2860
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@ast
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@en
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@nl
type
label
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@ast
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@en
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@nl
prefLabel
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@ast
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@en
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@nl
P2093
P2860
P356
P1433
P1476
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.
@en
P2093
Angelika D Manthripragada
Jiaheng Qiu
Jorgen H Olsen
Lene Wermuth
Soren Friis
P2860
P304
P356
10.1159/000325653
P577
2011-04-20T00:00:00Z